Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thierry Conroy

Showing results (71-80 of 119) with videos related to

Pageof 12
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2004
XELOX (capecitabine plus oxaliplatin): active first-line therapy for patients with metastatic colorectal cancerJim Cassidy, Josep Tabernero, Chris Twelves, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 3, 2007
Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102Laurent Bedenne, Pierre Michel, Olivier Bouché, et al.
Bulletin Du Cancer|November 24, 2004
[Clinical practice guideline: 2003 update of Standards, Options et Recommendations for first line palliative chemotherapy in patients with metastatic colorectal cancer (summary report)]Thierry Conroy, Guillaume Gory-Delabaere, Antoine Adenis, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 17, 2014
Radiation plus docetaxel and cisplatin in locally advanced pancreatic carcinoma: a non-comparative randomized phase II trialMichel Ducreux, Marc Giovannini, Charlotte Baey, et al.
Cancers|July 24, 2021
Anosmia but Not Ageusia as a COVID-19-Related Symptom among Cancer Patients-First Results from the PAPESCO-19 Cohort StudyKe Zhou, Audrey Blanc-Lapierre, Valérie Seegers, et al.
Cancers|October 14, 2023
COVID-19 Infection despite Previous Vaccination in Cancer Patients and Healthcare Workers: Results from a French Prospective Multicenter Cohort (PAPESCO-19)Valérie Seegers, Guillaume Rousseau, Ke Zhou, et al.
Oncology|April 18, 2008
Assessment of baseline clinical predictive factors of response to cetuximab-irinotecan in patients with irinotecan-refractory metastatic colorectal cancerMohamed Hebbar, Frédéric Di Fioré, Thierry Conroy, et al.
Seminars in Oncology|March 14, 2021
Gemcitabine plus nab-paclitaxel versus FOLFIRINOX for unresected pancreatic cancer: Comparative effectiveness and evaluation of tumor growth in VeteransKeith Sigel, Mengxi Zhou, Yeun-Hee Anna Park, et al.
Health and Quality of Life Outcomes|March 31, 2011
Cross-cultural development of an item list for computer-adaptive testing of fatigue in oncological patientsJohannes M Giesinger, Morten Aa Petersen, Mogens Groenvold, et al.
Cancers|November 26, 2022
COVID-19 Vaccination Campaign in Cancer Patients and Healthcare Workers-Results from a French Prospective Multicenter Cohort (PAPESCO-19)Valérie Seegers, Guillaume Rousseau, Ke Zhou, et al.
Pageof 12

Showing results (71-80 of 119) with videos related to

Sort By:
Pageof 12
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2004
XELOX (capecitabine plus oxaliplatin): active first-line therapy for patients with metastatic colorectal cancerJim Cassidy, Josep Tabernero, Chris Twelves, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 3, 2007
Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102Laurent Bedenne, Pierre Michel, Olivier Bouché, et al.
Bulletin Du Cancer|November 24, 2004
[Clinical practice guideline: 2003 update of Standards, Options et Recommendations for first line palliative chemotherapy in patients with metastatic colorectal cancer (summary report)]Thierry Conroy, Guillaume Gory-Delabaere, Antoine Adenis, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 17, 2014
Radiation plus docetaxel and cisplatin in locally advanced pancreatic carcinoma: a non-comparative randomized phase II trialMichel Ducreux, Marc Giovannini, Charlotte Baey, et al.
Cancers|July 24, 2021
Anosmia but Not Ageusia as a COVID-19-Related Symptom among Cancer Patients-First Results from the PAPESCO-19 Cohort StudyKe Zhou, Audrey Blanc-Lapierre, Valérie Seegers, et al.
Cancers|October 14, 2023
COVID-19 Infection despite Previous Vaccination in Cancer Patients and Healthcare Workers: Results from a French Prospective Multicenter Cohort (PAPESCO-19)Valérie Seegers, Guillaume Rousseau, Ke Zhou, et al.
Oncology|April 18, 2008
Assessment of baseline clinical predictive factors of response to cetuximab-irinotecan in patients with irinotecan-refractory metastatic colorectal cancerMohamed Hebbar, Frédéric Di Fioré, Thierry Conroy, et al.
Seminars in Oncology|March 14, 2021
Gemcitabine plus nab-paclitaxel versus FOLFIRINOX for unresected pancreatic cancer: Comparative effectiveness and evaluation of tumor growth in VeteransKeith Sigel, Mengxi Zhou, Yeun-Hee Anna Park, et al.
Health and Quality of Life Outcomes|March 31, 2011
Cross-cultural development of an item list for computer-adaptive testing of fatigue in oncological patientsJohannes M Giesinger, Morten Aa Petersen, Mogens Groenvold, et al.
Cancers|November 26, 2022
COVID-19 Vaccination Campaign in Cancer Patients and Healthcare Workers-Results from a French Prospective Multicenter Cohort (PAPESCO-19)Valérie Seegers, Guillaume Rousseau, Ke Zhou, et al.
Pageof 12